This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:David Canner/Sandbox 2
From Proteopedia
< User:David Canner(Difference between revisions)
| Line 5: | Line 5: | ||
{{TOC limit|limit=2}} | {{TOC limit|limit=2}} | ||
| - | + | **Alzheimer’s Disease | |
| - | [[Acetylcholinesterase]] | + | ***[[Acetylcholinesterase]] |
| - | [[Amyloid Beta]] | + | ***[[Amyloid Beta]] |
| - | [[Gamma-Secratase]] | + | ***[[Gamma-Secratase]] |
| - | [[Glutamate receptor (GluA2)]] | + | ***[[Glutamate receptor (GluA2)]] |
| - | + | **Anemia | |
| - | [[Erythropoietin]] | + | ***[[Erythropoietin]] |
| - | + | **Asthma and other Pulmonary Disease States | |
| - | [[Beta-2-Andrenergic Receptor]] | + | ***[[Beta-2-Andrenergic Receptor]] |
| - | [[Leukotriene Receptor]] | + | ***[[Leukotriene Receptor]] |
| - | + | **Autoimmune Diseases | |
| - | [[Tumor Necrosis Factor Receptor]] | + | ***[[Tumor Necrosis Factor Receptor]] |
| - | + | **Blood Clots & Thrombic Events | |
| - | [[P2Y12]] | + | ***[[P2Y12]] |
| - | **Cancer | + | **Cancer |
***Growth Factors | ***Growth Factors | ||
****Epidermal Growth Factor | ****Epidermal Growth Factor | ||
| Line 43: | Line 43: | ||
****[[Phosphatidylinositol 3-Kinase]] | ****[[Phosphatidylinositol 3-Kinase]] | ||
****[[Tyrosine Kinase]] | ****[[Tyrosine Kinase]] | ||
| - | **[[Heat Shock Protein 90]] | + | ***[[Heat Shock Protein 90]] |
| - | **[[p53]] | + | ***[[p53]] |
| - | **[[Mammalian Target of Rapamycin]] | + | ***[[Mammalian Target of Rapamycin]] |
| - | + | **Compromised Immune System | |
| - | [[Granulocyte-macrophage colony-stimulating factor]] | + | ***[[Granulocyte-macrophage colony-stimulating factor]] |
| - | + | **Diabetes & Hypoglycemia | |
| - | [[Peroxisome Proliferator-Activated Receptors]] | + | ***[[Peroxisome Proliferator-Activated Receptors]] |
| - | + | **Digestive Diseases | |
| - | [[Proton Pump]] | + | ***[[Proton Pump]] |
| - | + | **Erectile Dysfunction | |
| - | [[cGMP-Specific Phosphodiesterase Type 5]] | + | ***[[cGMP-Specific Phosphodiesterase Type 5]] |
| - | + | **HIV | |
| - | [[Reverse Transcriptase]] | + | ***[[Reverse Transcriptase]] |
| - | + | **Hypercholesterolemia (Elevated Cholesterol) | |
| - | [[HMG-CoA Reductase]] | + | ***[[HMG-CoA Reductase]] |
| - | + | **Hypertension & Congestive Heart Failure | |
| - | [[Angiotensin-Converting Enzyme]] | + | ***[[Angiotensin-Converting Enzyme]] |
| - | [[Calcium Channel]] | + | ***[[Calcium Channel]] |
| - | + | **Inflammation & Rheumatoid Arthritis | |
| - | [[Cyclooxygenase]] | + | ***[[Cyclooxygenase]] |
| - | + | **Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | |
| - | [[Dopamine Receptor]] | + | ***[[Dopamine Receptor]] |
| - | [[Andrenergic Receptor]] | + | ***[[Andrenergic Receptor]] |
| - | [[Histamine Receptor]] | + | ***[[Histamine Receptor]] |
| - | [[Opioid Receptor]] | + | ***[[Opioid Receptor]] |
}} | }} | ||
Current revision
The following is a list of major phamerceutical compound targets, organized by disease.
